CORRECTION—Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results
Portfolio Pulse from
Neuronetics, Inc. (NASDAQ: STIM) issued a correction regarding their financial outlook, stating they expect to achieve cash flow breakeven by Q3 2025, not Q2 2025, as previously reported.
November 13, 2024 | 12:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Neuronetics corrected its financial outlook, now expecting to achieve cash flow breakeven by Q3 2025 instead of Q2 2025.
The correction indicates a delay in achieving cash flow breakeven, which may negatively impact investor sentiment and short-term stock price. The change from Q2 to Q3 2025 suggests a longer timeline for financial stability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100